Literature DB >> 30616203

STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activation.

Roberta Santarelli1, Valentina Carillo1, Maria Anele Romeo1, Aurelia Gaeta2, Cristina Nazzari2, Roberta Gonnella1, Marisa Granato1, Gabriella D'Orazi3, Alberto Faggioni4, Mara Cirone5.   

Abstract

The Tyr705 STAT3 constitutive activation, besides promoting PEL cell survival, contributes to the maintenance of viral latency. We found indeed that its de-phosphorylation by AG490 induced KSHV lytic cycle. Moreover, Tyr705 STAT3 de-phosphorylation, mediated by the activation of tyrosine phosphatases, together with the increase of Ser727 STAT3 phosphorylation contributed to KSHV lytic cycle induction by TPA. We then observed that p53-p21 axis, essential for the induction of KSHV replication, was activated by the inhibition of Tyr705 and by the increase of Ser727 STAT3 phosphorylation. As a possible link between STAT3, p53-p21 and KSHV lytic cycle, we found that TPA and AG490 reduced the expression of KAP-1, promoting p53 stability, p21 transcription and KSHV lytic cycle activation in PEL cells.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  KAP-1; KSHV; Lytic cycle; STAT3; Ser727 STAT3; Tyr705 STAT3; p21; p53

Mesh:

Substances:

Year:  2019        PMID: 30616203     DOI: 10.1016/j.virol.2018.12.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.

Authors:  Gabriella D'Orazi; Marco Cordani; Mara Cirone
Journal:  Cell Mol Life Sci       Date:  2020-10-17       Impact factor: 9.261

2.  miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos.

Authors:  Shuyuan Wu; Zhaofu Wu; Huiling Xu; Jinli Zhang; Wenyi Gu; Xiaohua Tan; Zemin Pan; Dongdong Cao; Dongmei Li; Lei Yang; Dongmei Li; Yuanming Pan
Journal:  PeerJ       Date:  2022-04-15       Impact factor: 3.061

3.  Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells.

Authors:  Andrea Arena; Maria Anele Romeo; Rossella Benedetti; Maria Saveria Gilardini Montani; Mara Cirone
Journal:  Biomedicines       Date:  2022-03-22

4.  The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma.

Authors:  Zhongzhong Wan; Xingrun Li; Xinru Luo; Bofan Wang; Xiang Zhou; Ao Chen
Journal:  Aging (Albany NY)       Date:  2022-07-18       Impact factor: 5.955

5.  Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation.

Authors:  Shuai Liu; Zhangmengxue Lei; Jie Li; Liu Wang; Ran Jia; Zhongshun Liu; Congwei Jiang; Ying Gao; Mu Liu; Linlin Kuang; Zhikang Qian; Dongming Zhou; Samuel H Speck; Xiaozhen Liang
Journal:  PLoS Pathog       Date:  2020-07-31       Impact factor: 6.823

Review 6.  Regulation of KSHV Latency and Lytic Reactivation.

Authors:  Grant Broussard; Blossom Damania
Journal:  Viruses       Date:  2020-09-17       Impact factor: 5.048

7.  Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21.

Authors:  Roberta Santarelli; Chiara Pompili; Maria Saveria Gilardini Montani; Maria Anele Romeo; Roberta Gonnella; Gabriella D'Orazi; Mara Cirone
Journal:  IUBMB Life       Date:  2021-05-21       Impact factor: 3.885

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.